EMHTF - Emerald Health Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,948.421937.654253.32131.291
Cost of Revenue2,218.6311,223.171603.267203.802
Gross Profit-270.21-285.517-349.946-172.511
Operating Expenses
Research Development801.351207.5301.526162.316
Selling General and Administrative25,326.7925,498.9881,452.2151,931.201
Non Recurring----
Others----
Total Operating Expenses39,292.67710,034.6043,154.1443,520.129
Operating Income or Loss-37,344.256-9,096.95-2,900.823-3,488.838
Income from Continuing Operations
Total Other Income/Expenses Net6,337.237255.126-39.678-8.433
Earnings Before Interest and Taxes-37,344.256-9,096.95-2,900.823-3,488.838
Interest Expense-218.6-218.6-39.678-8.433
Income Before Tax-31,007.019-8,841.824-2,940.501-3,497.271
Income Tax Expense-23.611---
Minority Interest-1,956.8341,956.8341,956.834
Net Income From Continuing Ops-30,983.408-8,841.824-2,940.501-3,497.271
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-30,576.893-8,731.832-2,940.501-3,497.271
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-30,576.893-8,731.832-2,940.501-3,497.271